FAST vs IRD · P/E 43, rev $7.55B vs rev $11.0M
Fastenal Company (FAST) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. IRD currently screens at market cap $35.7M.
Not investment advice. Open the FAST and IRD stock pages for the full models.
Not investment advice.